Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02232750 · ClinicalTrials.gov registry record
Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 1,320
- Enrollment target
NCT02232750: Completed study, sponsored by Ohio State University.
NCT02232750 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 1,320 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02232750 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 1,320 participants
- Enrollment target
Study Summary
The investigators hypothesize that CPD parameters will provide improved prediction of sepsis compared to currently employed laboratory parameters. These studies hold the potential to shape practitioner guidelines and improve the timeliness and accuracy with which patients with sepsis are treated today.
Primary Outcome
Evaluate the clinical utility of CPD MNV as an aid in the diagnosis and risk assessment of Emergency Department patients for progression to sepsis, severe sepsis and septic shock.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,320 participants |
| Start Date | 2014-07-14 |
| Est. Completion | 2015-08-15 |
What the finished NCT02232750 record still lists
NCT02232750 is an observational study that tracks outcomes without assigning an intervention. Its 1,320 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02232750 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02232750 about?
NCT02232750 is a clinical study titled "Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)". The investigators hypothesize that CPD parameters will provide improved prediction of sepsis compared to currently employed laboratory parameters. These studies hold the potential to shape practitioner guidelines and improve the timeliness and accuracy with which patients with sepsis are treated tod...
What is the current status of trial NCT02232750?
This trial is currently completed. The enrollment target is 1,320 participants. The study started on 2014-07-14. Estimated completion is 2015-08-15.
Who is sponsoring clinical trial NCT02232750?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06557005 · 1,320 participants · NA
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
- NCT07213908 · 1,320 participants · NA
Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth
- NCT07144800 · 1,319 participants · NA
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
- NCT05097287 · 1,324 participants · Phase 4
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI